Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study

2009 ◽  
Vol 29 (2) ◽  
pp. 198-206 ◽  
Author(s):  
P. M. HELLSTRÖM ◽  
J. HEIN ◽  
P. BYTZER ◽  
E. BJÖRNSSÖN ◽  
J. KRISTENSEN ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Irritable Bowel Syndrome ◽  
Acute Pain ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Irritable Bowel

scholarly journals Double blind study of ispaghula in irritable bowel syndrome.

Gut ◽  
1987 ◽  
Vol 28 (11) ◽  
pp. 1510-1513 ◽  
Author(s):  
A Prior ◽  
P J Whorwell
Keyword(s):  
Irritable Bowel Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Irritable Bowel

Efficacy of bedelix® a therapeutic clay, in patients with irritable bowel syndrome: A placebo controlled double blind study

2003 ◽  
Vol 124 (4) ◽  
pp. A390
Author(s):  
Philippe Ducrotte ◽  
Michel Dapoigny ◽  
Bruno Bonaz ◽  
Laurent Siproudhis
Keyword(s):  
Irritable Bowel Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Irritable Bowel

Efficacy of carbon dioxide-insufflating colonoscopy in patients with irritable bowel syndrome: A randomized double-blind study

2012 ◽  
Vol 27 (10) ◽  
pp. 1623-1628 ◽  
Author(s):  
Aki Imai ◽  
Mototsugu Kato ◽  
Shouko Ono ◽  
Yuichi Shimizu ◽  
Hiroshi Takeda ◽  
...  
Keyword(s):  
Carbon Dioxide ◽  
Irritable Bowel Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Irritable Bowel
Sign in / Sign up

Export Citation Format

Share Document